| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2021-09-11 07:53:57 UTC |
|---|
| Update Date | 2022-07-18 23:53:32 UTC |
|---|
| HMDB ID | HMDB0250791 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | D-Phenylalanine |
|---|
| Description | (±)-Phenylalanine, also known as F, belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom (±)-Phenylalanine is an odorless tasting compound (±)-Phenylalanine is found, on average, in the highest concentration within a few different foods, such as red bell peppers (Capsicum annuum), wheats (Triticum), and oats (Avena sativa) and in a lower concentration in carp breams (Abramis brama), common lings (Molva molva), and rainbow smelts (Osmerus mordax) (±)-Phenylalanine has also been detected, but not quantified in, several different foods, such as oil palms (Elaeis), ucuhubas (Virola surinamensis), lard, cocoa butter, and beer. This could make (±)-phenylalanine a potential biomarker for the consumption of these foods (±)-Phenylalanine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Based on a literature review a significant number of articles have been published on (±)-Phenylalanine. This compound has been identified in human blood as reported by (PMID: 31557052 ). D-phenylalanine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically D-Phenylalanine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12) |
|---|
| Synonyms | | Value | Source |
|---|
| alpha-Amino-beta-phenylpropionic acid | ChEBI | | DL-Phenylalanine | ChEBI | | F | ChEBI | | Fenilalanina | ChEBI | | PHE | ChEBI | | Phenylalanin | ChEBI | | a-Amino-b-phenylpropionate | Generator | | a-Amino-b-phenylpropionic acid | Generator | | alpha-Amino-beta-phenylpropionate | Generator | | Α-amino-β-phenylpropionate | Generator | | Α-amino-β-phenylpropionic acid | Generator | | L-Isomer phenylalanine | MeSH | | Endorphenyl | MeSH | | L-Phenylalanine | MeSH | | Phenylalanine | MeSH | | Phenylalanine, L isomer | MeSH | | Phenylalanine, L-isomer | MeSH |
|
|---|
| Chemical Formula | C9H11NO2 |
|---|
| Average Molecular Weight | 165.1891 |
|---|
| Monoisotopic Molecular Weight | 165.078978601 |
|---|
| IUPAC Name | 2-amino-3-phenylpropanoic acid |
|---|
| Traditional Name | phenylalanin |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | NC(CC1=CC=CC=C1)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12) |
|---|
| InChI Key | COLNVLDHVKWLRT-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Phenylalanine and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenylalanine or derivatives
- 3-phenylpropanoic-acid
- Alpha-amino acid
- Amphetamine or derivatives
- Aralkylamine
- Monocyclic benzene moiety
- Benzenoid
- Amino acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Organic nitrogen compound
- Primary amine
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Carbonyl group
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 10.0864 minutes | 33406817 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 669.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 320.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 92.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 182.8 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 79.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 270.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 292.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 664.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 717.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 219.3 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 773.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 181.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 237.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 450.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 373.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 200.7 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| D-Phenylalanine,2TMS,isomer #1 | C[Si](C)(C)NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C | 1628.6 | Semi standard non polar | 33892256 | | D-Phenylalanine,2TMS,isomer #1 | C[Si](C)(C)NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C | 1664.3 | Standard non polar | 33892256 | | D-Phenylalanine,2TMS,isomer #1 | C[Si](C)(C)NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C | 1948.3 | Standard polar | 33892256 | | D-Phenylalanine,2TMS,isomer #2 | C[Si](C)(C)N(C(CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 1767.2 | Semi standard non polar | 33892256 | | D-Phenylalanine,2TMS,isomer #2 | C[Si](C)(C)N(C(CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 1741.2 | Standard non polar | 33892256 | | D-Phenylalanine,2TMS,isomer #2 | C[Si](C)(C)N(C(CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C | 2119.8 | Standard polar | 33892256 | | D-Phenylalanine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C | 1829.5 | Semi standard non polar | 33892256 | | D-Phenylalanine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C | 1789.9 | Standard non polar | 33892256 | | D-Phenylalanine,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C | 1938.7 | Standard polar | 33892256 | | D-Phenylalanine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C | 2070.9 | Semi standard non polar | 33892256 | | D-Phenylalanine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C | 2086.0 | Standard non polar | 33892256 | | D-Phenylalanine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(CC1=CC=CC=C1)C(=O)O[Si](C)(C)C(C)(C)C | 2231.1 | Standard polar | 33892256 | | D-Phenylalanine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 2211.6 | Semi standard non polar | 33892256 | | D-Phenylalanine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 2161.7 | Standard non polar | 33892256 | | D-Phenylalanine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(CC1=CC=CC=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 2305.7 | Standard polar | 33892256 | | D-Phenylalanine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2455.2 | Semi standard non polar | 33892256 | | D-Phenylalanine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2394.5 | Standard non polar | 33892256 | | D-Phenylalanine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2287.5 | Standard polar | 33892256 |
|
|---|
| Disease References | | Sepsis |
|---|
- Ferrario M, Cambiaghi A, Brunelli L, Giordano S, Caironi P, Guatteri L, Raimondi F, Gattinoni L, Latini R, Masson S, Ristagno G, Pastorelli R: Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach. Sci Rep. 2016 Feb 5;6:20391. doi: 10.1038/srep20391. [PubMed:26847922 ]
|
|
|---|